VILAZODONE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vilazodone Hydrochloride, and what generic alternatives are available?
Vilazodone Hydrochloride is a drug marketed by Accord Hlthcare, Alembic, Apotex, Invagen Pharms, and Teva Pharms Usa. and is included in five NDAs.
The generic ingredient in VILAZODONE HYDROCHLORIDE is vilazodone hydrochloride. There are fourteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the vilazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vilazodone Hydrochloride
A generic version of VILAZODONE HYDROCHLORIDE was approved as vilazodone hydrochloride by TEVA PHARMS USA on September 30th, 2019.
Summary for VILAZODONE HYDROCHLORIDE
Recent Clinical Trials for VILAZODONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Alliance on Mental Illness Westside Los Angeles | |
National Alliance on Mental Illness | |
Risk Benefit Statistics LLC |
Medical Subject Heading (MeSH) Categories for VILAZODONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for VILAZODONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for VILAZODONE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
VIIBRYD | Tablets | vilazodone hydrochloride | 10 mg, 20 mg, and 40 mg | 022567 | 5 | 2015-01-21 |